toll free: 1800 3070 6727 Email: email@example.com
All Colorectal Cancer patients
Family history of Colorectal Cancer
Family member with a known mutation in MLH1, MSH2, MSH6, PMS2, APC, MUTYH and EPCAM genes
Know risk to secondary cancers in Colorectal cancer patients who are positive for Lynch syndrome
Determine risk of hereditary colorectal cancer in men and women; and uterine or endometrial cancer in women
Sample Requirement: 3-4ml of blood in EDTA tube
NABL and DSIR certified laboratory
Reporting time: 4 weeks
Download sample report
PositiveScreen Lynch analyzes MSH6, MSH2, MLH1, PMS2, APC, MUTYH and EPCAM genes for mutations. MMR, MUTYH and APC gene mutation analyzed are associated with Lynch Syndrome/Hereditary Non-Polyposis Colorectal Cancer (HNPCC) syndrome. This test will help determine if a person has a significantly increased risk of developing lynch syndrome due to a mutation(s) in a cancer-predisposing gene(s). PositiveScreen Lynch is included in PositiveScreen Hereditary Cancer.
Better understand a patients’ risk for specific health conditions
Prescribe more suitable medications at optimal dosages for patients, as needed.
Suggest early lifestyle and diet interventions to help control or prevent certain health conditions.
Determine risk of developing hereditary colorectal cancer in men and women
Determine risk of developing hereditary uterine/endometrial cancer in women
Industry leading 51 gene tes
Learn your risk for 11 cancers
Know risk to secondary cancers in cancer patients
Sample Requirement: 3-4ml of Blood in myRisk kit
CAP and CLIA certified laboratory
533, Kalbadevi Road,
Mumbai – 400002